Cargando…
Circulating Tumor Cells: What Is in It for the Patient? A Vision towards the Future
Knowledge on cellular signal transduction pathways as drivers of cancer growth and metastasis has fuelled development of “targeted therapy” which “targets” aberrant oncogenic signal transduction pathways. These drugs require nearly invariably companion diagnostic tests to identify the tumor-driving...
Autores principales: | van de Stolpe, Anja, den Toonder, Jaap M. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074824/ https://www.ncbi.nlm.nih.gov/pubmed/24879438 http://dx.doi.org/10.3390/cancers6021195 |
Ejemplares similares
-
What Froze the Genetic Code?
por: Ribas de Pouplana, Lluís, et al.
Publicado: (2017) -
Towards a People’s Social Epidemiology: Envisioning a More Inclusive and Equitable Future for Social Epi Research and Practice in the 21st Century
por: Petteway, Ryan, et al.
Publicado: (2019) -
What Motivates Speculators to Speculate?
por: Gemeda, Bedane S., et al.
Publicado: (2019) -
Future Challenges in Heterogeneous Catalysis: Understanding Catalysts under Dynamic Reaction Conditions
por: Kalz, Kai F., et al.
Publicado: (2016) -
Doing What We Know, Knowing What to Do: Californians Linking Action with Science for Prevention of Breast Cancer (CLASP-BC)
por: Kerner, Jon F., et al.
Publicado: (2020)